The Danish government is putting pressure on the country’s DKr5.5tn (€737bn) pensions industry to invest more in the domestic ...

Novo Nordisk A/S (NYSE:NVO) is among the most profitable healthcare stocks to buy. On January 26, BMO Capital lifted the ...

There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...

However, Novo Nordisk has a plan to get things back on track, and the company's oral Wegovy is part of that strategy. In ...

Novo Nordisk A/S gains in GLP-1 obesity pills with strong U.S. marketing. Click for this NVO stock update and a preview of ...

"Everybody has some relationship to Novo Nordisk and everybody's pension has stocks in Novo," said Sebastian Henry ...

Effective prevention and management of T2DM can improve patient outcomes and reduce health care-related environmental impact.

What was once a barren field five years ago is now in a “virtuous cycle,” a transformation Darsow felt firsthand as the Novo ...

The healthcare sector lagged broader equities last year. Novo Nordisk ( NVO 2.86%) and Merck ( MRK 0.62%), two pharmaceutical ...

Denmark has begun a government analysis of small modular reactors to explore their role in energy security, safety, and ...

Danish national registry data suggest adults with type 2 diabetes taking SGLT2 inhibitors have a slightly lower risk of developing diabetic foot problems than those taking GLP-1 receptor agonists.